PubMed

US Food and Drug Administration Clearance of Moderate-Risk Otolaryngologic Devices via the 510(k) Process, 1997-2016.

PMID: 28786317 · 2017-08-08

V, i, n, a, y, , K, , R, a, t, h, i, ;, , S, h, e, k, h, a, r, , K, , G, a, d, k, a, r, e, e, ;, , J, o, s, e, p, h, , S, , R, o, s, s, ;, , E, l, l, i, o, t, t, , D, , K, o, z, i, n, ;, , R, o, s, h, , K, , S, e, t, h, i, ;, , M, a, t, t, h, e, w, , R, , N, a, u, n, h, e, i, m, ;, , S, i, d, h, a, r, t, h, , V, , P, u, r, a, m, ;, , S, t, a, c, e, y, , T, , G, r, a, y

학술지Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

연도2017-08-08

PMID28786317

초록

Objective The US Food and Drug Administration (FDA) clears moderate-risk devices via the 510(k) process based on substantial equivalence to previously cleared devices; evidence of safety and effectiveness is not required. We characterized the premarket evidence supporting FDA clearance of otolaryngologic devices. Study Design Retrospective cross-sectional analysis. Setting Publicly available FDA documents. Subjects and Methods Recently cleared (1997-2016) moderate-risk otolaryngologic devices we

공식 출처

PubMed에서 보기 →

데이터는 PubMed / NCBI에서 제공됩니다. 전문과 최신 정보는 반드시 공식 기록을 확인하세요.